Alerts will be sent to your verified email
Verify Email
VISTAPH
|
Vista Pharma
|
Lasa Supergenerics
|
Shanmuga Hospital
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-9.01 % | -8.32 % | 44.19 % |
|
5yr average Equity Multiplier
|
1.42 | 1.44 | 1.69 |
|
5yr Average Asset Turnover Ratio
|
0.08 | 0.77 | 1.83 |
|
5yr Avg Net Profit Margin
|
-205.63 % | -8.22 % | 13.07 % |
|
Price to Book
|
1.05 | 0.61 | 1.34 |
|
P/E
|
0.0 | 0.0 | 12.67 |
|
5yr Avg Cash Conversion Cycle
|
124.89 Days | 11.27 Days | -11.46 Days |
|
Inventory Days
|
3040.44 Days | 46.83 Days | 13.93 Days |
|
Days Receivable
|
137.33 Days | 10.61 Days | 59.96 Days |
|
Days Payable
|
1845.08 Days | 83.41 Days | 51.52 Days |
|
5yr Average Interest Coverage Ratio
|
-2.88 | -18.91 | 80.15 |
|
5yr Avg ROCE
|
-8.17 % | 1.03 % | 54.92 % |
|
5yr Avg Operating Profit Margin
|
-192.46 % | 9.99 % | 20.54 % |
|
5 yr average Debt to Equity
|
0.26 | 0.2 | 0.34 |
|
5yr CAGR Net Profit
|
19.73 % | n/a | -8.93 % |
|
5yr Average Return on Assets
|
-6.49 % | -5.59 % | 26.81 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
21.19 % | 53.65 % | 72.06 % |
|
Share Pledged by Promoters
|
0.0 | 20.66 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.25 % | 9.87 % | 0.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.02 % | 0.0 | 0.0 |
|
Vista Pharma
|
Lasa Supergenerics
|
Shanmuga Hospital
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|